The Faculty of Medicine, UPJŠ organized the first national meeting SLOVACRIN

    The first national meeting SLOVACRIN was held on the occasion of the establishment of the Slovak academic research infrastructure, the part of European research infrastructure ECRIN-ERIC, at the DoubleTree by Hilton Hotel in Košice on Friday, March 22, 2019.
    The event was organized by the Faculty of Medicine, UPJŠ, the national scientific partner of that pan-European organization focused on various forms of academic clinical research and international biomedical scientific projects. The FM UPJŠ is going to coordinate all activities of this research infrastructure implemented in the Slovak Republic under the auspices of the Ministry of Health of the Slovak Republic.
    “ECRIN (European Clinical Research Infrastructure Network) is a non-profit association which connects scientific partners and networks across the Europe.The Slovak Republic became a part of this pan-European organization focused on all forms of clinical research last year, while the foundations of the establishment of the Slovak Clinical Research Infrastructure Network – SLOVACRIN have been carefully prepared since 2017. Slovakia was introduced as a candidate country and subsequently admitted as an observer country after demanding negotiations at the ECRIN Assembly of Members in May 2018. The national foundations of the future network were laid at a meeting at the Ministry of Health of the Slovak Republic on 11th September, 2018,” explains the Dean of the Faculty of Medicine, UPJŠ and the CEO of SLOVACRIN prof. Daniel Pella, M.D., PhD.   
    The current members of ECRIN are France, Germany, Hungary, Italy, Norway, Ireland, Portugal, Spain and the Czech Republic. The Slovak Republic, like Switzerland, has an observer status so far, which means that they have only an advisory vote, but have gained full access to the full range of the ECRIN services. The observer status also allows us the full access to the ECRIN support and enables us the full involvement in the international space of academic clinical trials.
    A great advantage of the cooperation of Slovakia with this European research infrastructure is the possibility of involving Slovak doctors and researchers in the pre-clinical and clinical research and cooperation with similarly oriented European workplaces, that represent the absolute top in the field.

---